← Eichor
Study identifier: NCT05061680 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Quick Large Balloon Dilatation for Removal of Large Bile Duct Stones (SHODBADI)

Condition: Pancreatitis, Acute · Bleeding · Cholangitis  ·  Sponsor: Helsinki University Central Hospital

PhaseNA
Planned participants600
Who can joinAll sexes, 18 Years to 95 Years
Healthy volunteersNo

About this study

ESGE guidelines suggests 30-60 seconds endoscopic large balloon papillary dilation from the disappearance of the waist of the papilla. The investigators have good results in stone removal with much quicker dilatations when the cholangiogram is followed and the dilation is finished as soon as the disappearance of the waist of the papilla is seen. This Scandinavian multicenter prospective study is especially interested in stone clearance rate and short and long-term adverse events such as pancreatitis, cholangitis, bleeding, perforations, residual biliary stones, and newly developing biliary stones.

This description comes directly from the study's public registry record.

Talk to the study team

Mia Rainio, MD, PhD  ·  +358505833060  ·  mia.rainio@hus.fi

Leena Kylänpää, MD, PhD  ·  +35894711  ·  leena.kylanpaa@hus.fi

Always discuss trial participation with your own doctor first.

Locations (2)

Helsinki University HospitalHelsinki, FinlandRecruiting
Turku University HospitalTurku, FinlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05061680